Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine brachial plexus block concentrations in arthroscopic shoulder surgery
ChiCTR2400089536Phase 4Recruiting
- Sponsor
- Zhuji People's Hospital of Zhejiang Province
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by Zhuji People's Hospital of Zhejiang Province. Primary endpoint: 48 hour postoperative resting NRS score. Started Sep 2024; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2400089536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400089536.